Room Temperature Vaccines Pass First Human Trial
A UK company has tested fridge-free vaccines on people for the first time. Stablepharma gave 60 volunteers a tetanus-diphtheria vaccine that had been stored as a dry powder at room temperature for a year before being mixed with water and injected. The technology copies resurrection plants, which make a sugar called trehalose to protect their cells during droughts. The National Institute for Health and Care Research funded the work.
Half of all vaccines are wasted each year because they get too hot or too cold during storage and transport. Temperature-stable vaccines could end that waste, particularly in poor and remote areas where refrigeration is scarce.
Source: bbc.com.
Written by the HappyGood desk from the primary source linked above and checked against it. Every story links its source. Corrections: [email protected].
More from the archive
- Bringing back the American chestnut: four approaches to a forest giant's return October 14, 2026
- 5 search and rescue teams, RCMP find stranded person in canyon above Penticton October 14, 2026
- Mackenzie Macdonald, 16, heads to the Youth Olympics for Australia in taekwondo October 13, 2026
- Parksville festival volunteers help deliver record $89,270 donation October 12, 2026
- Police fetch antivenom as three Blue Mountains rescues unfold in a day October 12, 2026